• CSBTA Pharmacokinetics in MASH Mice: Key Insights

  2026-08-19

  A 2025 study integrated plasma pharmacokinetics, tissue distribution, transporter assays, microsomal metabolism, and enzyme-expression analysis to explain how MASH alters exposure to Corydalis saxicola Bunting total alkaloids. Its findings indicate that disease state and repeated dosing can increase systemic and hepatic accumulation, with implications for disease-adapted dosing and pharmacokinetic monitoring.

• Sulfo-Cy3 azide for Neurodevelopmental Mapping

  2026-08-18

  Sulfo-Cy3 azide is a water-compatible bioconjugation reagent for translating embryonic birthdating maps into quantitative fluorescence assays. This guide connects the dye’s click-labeling chemistry with the EdU and Nurr1 findings of rat claustrum development while emphasizing assay design, controls, and biological limitations.

• Dacarbazine: From DNA Damage to Translation

  2026-08-18

  A translational framework for using Dacarbazine to connect DNA alkylation, experimental design, supportive-care strategy, and clinical decision-making across melanoma, lymphoma, and sarcoma research.

• Phytol: A Design Framework for Mechanistic Assays

  2026-08-17

  Phytol is a multifunctional diterpene that links retinoid X receptor signaling, metabolism, and GABAergic transmission modulation. This article presents an assay-design framework for separating these mechanisms and uses polymer self-assembly research to clarify how experimental architecture affects interpretation.

• Promethazine HCl: From H1 Blockade to Assay Design

  2026-08-17

  Promethazine HCl is more than a histamine antagonist: it is a useful probe for separating receptor-proximal signaling from macrophage ROS and autophagy phenotypes. This guide translates phenothiazine host-directed immunity findings into rigorous assay design, controls, and cross-domain research decisions.

• Polyphyllin H Reverses Paclitaxel Resistance

  2026-08-15

  A 2025 study identifies membrane cholesterol and lipid rafts as actionable regulators of paclitaxel resistance in breast cancer. Polyphyllin H restored drug sensitivity by simultaneously suppressing ABCB1 and ABCC3, providing a mechanistic alternative to single-transporter inhibition.

• DFO for Latent Fingerprint Detection

  2026-08-14

  DFO combines amino-acid reactivity with fluorescence to improve latent print visualization on paper and other porous evidence. This practical guide covers reagent setup, fresh-solution handling, imaging controls, cross-domain assay lessons, and troubleshooting for more reproducible forensic workflows.

• MLN8237 (Alisertib) Research Workflows

  2026-08-14

  Build more informative Aurora A experiments with MLN8237 (Alisertib), from concentration-response and mitotic assays to apoptosis and trained-immunity studies. This workflow connects kinase selectivity with chromatin accessibility, SAM metabolism, and tumor biology while emphasizing controls, exposure design, and troubleshooting.

• Cefoperazone: From MIC to Biliary Models

  2026-08-13

  Cefoperazone sodium salt connects β-lactamase-resistance studies with compartment-aware infection modeling. This article explains how to interpret MIC, MBC, chemical stability, and biliary distribution without confusing in vitro potency with tissue-level efficacy.

• GSK126 Workflow for EZH2 Mechanism Studies

  2026-08-13

  GSK126 enables controlled interrogation of PRC2-dependent gene silencing across cancer epigenetics research, including EZH2-mutant lymphoma and solid-tumor models. This workflow also shows how the compound can be used cautiously to test links between EZH2, autophagy, and neuroinflammation without confusing a research tool result with therapeutic validation.

• JC-1 for Reliable Mitochondrial Assays

  2026-08-12

  JC-1 (SKU A3516) offers a practical ratiometric approach to mitochondrial membrane potential assays, apoptosis detection, and cellular bioenergetics studies. This scenario-based guide explains stock preparation, compatibility, optimization, interpretation, and vendor-selection considerations without treating JC-1 as a standalone measure of cell viability.

• Rocilinostat (ACY-1215): HDAC6 Research Guide

  2026-08-12

  Rocilinostat, also called ACY-1215, is a selective HDAC6 inhibitor with a supplier-reported IC50 of 5 nM. Preclinical multiple myeloma studies associate HDAC6 inhibition with reduced tumor-cell viability, increased apoptosis, and enhanced responses to proteasome inhibitors.

• Lipo3K Transfection Reagent: Practical Workflows

  2026-08-11

  Lipo3K Transfection Reagent supports flexible DNA, siRNA, and mRNA delivery in adherent, suspension, and difficult-to-transfect cells. This practical guide connects low-toxicity transfection with responsive antisense assays, co-transfection design, optimization screens, and troubleshooting decisions.

• DRB for Transcriptional Elongation Studies

  2026-08-11

  Use DRB to dissect RNA polymerase II-dependent transcription, CDK signaling, and the boundary between transcript production and translation. This workflow-focused guide combines dose–time optimization, orthogonal RNA readouts, and practical controls for stem-cell, antiviral, and mechanistic studies.

• a-MSH, amide: A Mechanism-to-Assay Guide

  2026-08-10

  a-MSH, amide is more than a pigmentation stimulus: it is a defined receptor-probing reagent for separating melanocortin signaling from downstream melanin synthesis. This guide translates the αMSH/B16F10 literature into practical assay design, peptide handling, controls, and interpretation for pigmentation and inflammation research.

16411 records 1/1095 page Next 12345 下5页 Last page